
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Therapeutic application of the CRISPR system: current issues and new prospects
Minyoung Lee, Seokjoong Kim
Human Genetics (2019) Vol. 138, Iss. 6, pp. 563-590
Closed Access | Times Cited: 22
Minyoung Lee, Seokjoong Kim
Human Genetics (2019) Vol. 138, Iss. 6, pp. 563-590
Closed Access | Times Cited: 22
Showing 22 citing articles:
CRISPR-Cas systems: Overview, innovations and applications in human disease research and gene therapy
Yuanyuan Xu, Zhanjun Li
Computational and Structural Biotechnology Journal (2020) Vol. 18, pp. 2401-2415
Open Access | Times Cited: 247
Yuanyuan Xu, Zhanjun Li
Computational and Structural Biotechnology Journal (2020) Vol. 18, pp. 2401-2415
Open Access | Times Cited: 247
Aptamer/Peptide‐Functionalized Genome‐Editing System for Effective Immune Restoration through Reversal of PD‐L1‐Mediated Cancer Immunosuppression
Xiaoyan He, Xiaohe Ren, Yan Peng, et al.
Advanced Materials (2020) Vol. 32, Iss. 17
Closed Access | Times Cited: 115
Xiaoyan He, Xiaohe Ren, Yan Peng, et al.
Advanced Materials (2020) Vol. 32, Iss. 17
Closed Access | Times Cited: 115
Gene therapy: a double-edged sword with great powers
Ran Tang, Zhigang Xu
Molecular and Cellular Biochemistry (2020) Vol. 474, Iss. 1-2, pp. 73-81
Closed Access | Times Cited: 87
Ran Tang, Zhigang Xu
Molecular and Cellular Biochemistry (2020) Vol. 474, Iss. 1-2, pp. 73-81
Closed Access | Times Cited: 87
The DMD gene and therapeutic approaches to restore dystrophin
F. Fortunato, Marianna Farnè, Alessandra Ferlini
Neuromuscular Disorders (2021) Vol. 31, Iss. 10, pp. 1013-1020
Closed Access | Times Cited: 42
F. Fortunato, Marianna Farnè, Alessandra Ferlini
Neuromuscular Disorders (2021) Vol. 31, Iss. 10, pp. 1013-1020
Closed Access | Times Cited: 42
Exploring the Therapeutic Potential of Gene Therapy in Arrhythmogenic Right Ventricular Cardiomyopathy
Juan Mundisugih, Dhanya Ravindran, Eddy Kizana
Biomedicines (2024) Vol. 12, Iss. 6, pp. 1351-1351
Open Access | Times Cited: 4
Juan Mundisugih, Dhanya Ravindran, Eddy Kizana
Biomedicines (2024) Vol. 12, Iss. 6, pp. 1351-1351
Open Access | Times Cited: 4
Allele-specific genome targeting in the development of precision medicine
Junjiao Wu, Beisha Tang, Yu Tang
Theranostics (2020) Vol. 10, Iss. 7, pp. 3118-3137
Open Access | Times Cited: 29
Junjiao Wu, Beisha Tang, Yu Tang
Theranostics (2020) Vol. 10, Iss. 7, pp. 3118-3137
Open Access | Times Cited: 29
Synthetic Biology and Tissue Engineering: Toward Fabrication of Complex and Smart Cellular Constructs
Tyler Hoffman, Petar Antovski, Peyton Tebon, et al.
Advanced Functional Materials (2020) Vol. 30, Iss. 26
Closed Access | Times Cited: 29
Tyler Hoffman, Petar Antovski, Peyton Tebon, et al.
Advanced Functional Materials (2020) Vol. 30, Iss. 26
Closed Access | Times Cited: 29
Gene Therapy in Cardiology: Is a Cure for Hypertrophic Cardiomyopathy on the Horizon?
E. Paratz, Juan Mundisugih, S. Rowe, et al.
Canadian Journal of Cardiology (2023) Vol. 40, Iss. 5, pp. 777-788
Open Access | Times Cited: 11
E. Paratz, Juan Mundisugih, S. Rowe, et al.
Canadian Journal of Cardiology (2023) Vol. 40, Iss. 5, pp. 777-788
Open Access | Times Cited: 11
CRISPR/Cas9 in cancer therapy: A review with a special focus on tumor angiogenesis
Krishnasamy Naidu Gopal Hariprabu, Sathya Muthusamy, Selvaraj Vimalraj
International Journal of Biological Macromolecules (2021) Vol. 192, pp. 913-930
Closed Access | Times Cited: 19
Krishnasamy Naidu Gopal Hariprabu, Sathya Muthusamy, Selvaraj Vimalraj
International Journal of Biological Macromolecules (2021) Vol. 192, pp. 913-930
Closed Access | Times Cited: 19
Auditing the Editor: A Review of Key Translational Issues in Epigenetic Editing
Katherine Huerne, Nicole Palmour, Angela Ruohao Wu, et al.
The CRISPR Journal (2022) Vol. 5, Iss. 2, pp. 203-212
Open Access | Times Cited: 11
Katherine Huerne, Nicole Palmour, Angela Ruohao Wu, et al.
The CRISPR Journal (2022) Vol. 5, Iss. 2, pp. 203-212
Open Access | Times Cited: 11
Sonogenetics in the Treatment of Chronic Diseases: A New Method for Cell Regulation
Min Zhu, Yan Fang, Yi-Kang Sun, et al.
Advanced Science (2024)
Open Access | Times Cited: 2
Min Zhu, Yan Fang, Yi-Kang Sun, et al.
Advanced Science (2024)
Open Access | Times Cited: 2
Preparation of carbon dot as a potential CRISPR/Cas9 plasmid delivery system for lung cancer cells
Reza Mohammadinejad, Ali Dehshahri, Hosseinali Sassan, et al.
Minerva Biotecnologica (2020) Vol. 32, Iss. 3
Closed Access | Times Cited: 16
Reza Mohammadinejad, Ali Dehshahri, Hosseinali Sassan, et al.
Minerva Biotecnologica (2020) Vol. 32, Iss. 3
Closed Access | Times Cited: 16
Molecular Marvels: Small Molecules Paving the Way for Enhanced Gene Therapy
Sebastian Hasselbeck, Xinlai Cheng
Pharmaceuticals (2023) Vol. 17, Iss. 1, pp. 41-41
Open Access | Times Cited: 4
Sebastian Hasselbeck, Xinlai Cheng
Pharmaceuticals (2023) Vol. 17, Iss. 1, pp. 41-41
Open Access | Times Cited: 4
Artificial T Cell Adaptor Molecule-Transduced TCR-T Cells Demonstrated Improved Proliferation Only When Transduced in a Higher Intensity
Toshiyasu Sakai, Seitaro Terakura, Kotaro Miyao, et al.
Molecular Therapy — Oncolytics (2020) Vol. 18, pp. 613-622
Open Access | Times Cited: 10
Toshiyasu Sakai, Seitaro Terakura, Kotaro Miyao, et al.
Molecular Therapy — Oncolytics (2020) Vol. 18, pp. 613-622
Open Access | Times Cited: 10
Addressing the dark matter of gene therapy: technical and ethical barriers to clinical application
Kateryna Kratzer, Landon J. Getz, Thibaut Peterlini, et al.
Human Genetics (2021) Vol. 141, Iss. 6, pp. 1175-1193
Closed Access | Times Cited: 9
Kateryna Kratzer, Landon J. Getz, Thibaut Peterlini, et al.
Human Genetics (2021) Vol. 141, Iss. 6, pp. 1175-1193
Closed Access | Times Cited: 9
CRISPR Challenges and Opportunities for Space Travel
Arvin M. Gouw
Space and society (2020), pp. 19-34
Closed Access | Times Cited: 6
Arvin M. Gouw
Space and society (2020), pp. 19-34
Closed Access | Times Cited: 6
Sequence-specific retrotransposition of 28S rDNA-specific LINE R2Ol in human cells
Yu-Ting Su, Narisu Nichuguti, Azusa Kuroki-Kami, et al.
RNA (2019) Vol. 25, Iss. 11, pp. 1432-1438
Open Access | Times Cited: 5
Yu-Ting Su, Narisu Nichuguti, Azusa Kuroki-Kami, et al.
RNA (2019) Vol. 25, Iss. 11, pp. 1432-1438
Open Access | Times Cited: 5
Molecular Marvels: Small Molecules Paving the Way for Enhanced Gene Therapy
Sebastian Hasselbeck, Xinlai Cheng
(2023)
Open Access | Times Cited: 1
Sebastian Hasselbeck, Xinlai Cheng
(2023)
Open Access | Times Cited: 1
CRISPR/Cas9 technologies in epigenetics research
John M. Schoelz, Nicole C. Riddle
Elsevier eBooks (2020), pp. 537-567
Closed Access | Times Cited: 2
John M. Schoelz, Nicole C. Riddle
Elsevier eBooks (2020), pp. 537-567
Closed Access | Times Cited: 2
The role of externalities and uncertainty in policy design: evidence from the regulation of genome editing
Alberto Asquer, Inna Krachkovskaya
Policy Design and Practice (2021) Vol. 5, Iss. 2, pp. 140-151
Open Access | Times Cited: 1
Alberto Asquer, Inna Krachkovskaya
Policy Design and Practice (2021) Vol. 5, Iss. 2, pp. 140-151
Open Access | Times Cited: 1
Novel Strategies for Combating Antimicrobial Resistance: Alternative Agents on the Horizon
Ivy Ann Marie Navales, Meshael Ayisha Paglas, Ruziel Panibon, et al.
International Journal of Research Publication and Reviews (2023) Vol. 4, Iss. 12, pp. 3744-3759
Open Access
Ivy Ann Marie Navales, Meshael Ayisha Paglas, Ruziel Panibon, et al.
International Journal of Research Publication and Reviews (2023) Vol. 4, Iss. 12, pp. 3744-3759
Open Access